Stock Price
55.59
Daily Change
0.38 0.69%
Monthly
5.24%
Yearly
12.85%
Q2 Forecast
51.53

Bio Techne reported $140.43M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Illumina USD 1.59B 377M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Standard Biotools USD 108.31M 343K Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Waters USD 1.24B 11.8M Dec/2025